Most of the models used in these preclinical AD studies are transgenic mice bearing human familial AD-mutated gene copies, and predominantly mutated human APP (Ager et al. 2015; Blurton-Jones et al. 2009; Lee et al. 2015; McGinley et al. 2018). Here, APP is linked to Alzheimer disease.